TEAPOT Study Multisite
Part of paid clinical trials in Davis, California.
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study ID
- NCT07565753
- Phase
- EARLY_PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hemorrhage, Surgical
- Tonsillar Bleeding
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Tranexamic Acid Injectable Product — DRUGParticipants will receive three doses of TXA 500 mg (5 mL of TXA 100mg/ml) nebulized using a PARI LC D Disposable Nebulizer or equivalent over 10-15 minutes using 8 or greater liter/minute of gas flow.
- Normal Saline — OTHERParticipants will receive three 5 ml doses of placebo (normal saline) nebulized using a PARI LC D Disposable Nebulizer or equivalent over 10-15 minutes using 8 or greater liter/minute of gas flow.
Study Details
After a child has their tonsils removed, sometimes they might bleed which can be a problem. There is a special mist medicine called nebulized tranexamic acid (TXA) that might help stop the bleeding without having to touch the sore spot. If this mist works well, it could help kids get better by making sure they don't have to go back for more surgery or need blood from someone else. Not having another surgery is good because it means kids won't have to sleep under medicine again, which can sometimes be risky for their brains and breathing, and they won't feel as scared or hurt.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Nebulized Tranexamic AcidSubjects will be adminstered nebulized TXA post-tonsillectomy if they return to the emergency room with hemorrhage after surgery
- Placebo Comparator: Nebulized SalineSubjects will be adminstered nebulized saline post-tonsillectomy if they return to the emergency room with hemorrhage after surgery
Primary Outcome Measure
Number of patients enrolled per month [ Time Frame: Baseline to 18 months (or duration of study approximately 18 months) ]
Central Contacts
- Andrew D Meyer, MD, MS210-567-4424
- Stephanie Perez, MHA(210) 450-8973
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California at Davis Medical Center | Davis | California | 95819 | Daniel Nishijima, MD |
| Hasbro Childrens' Hospital | Providence | Rhode Island | 02903 | |
| University Hospital | San Antonio | Texas | 78229 |
Find similar trials in Davis, CA
Related Studies
- TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot StudyEARLY_PHASE1 · Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas